E-mail a Wiley Online Library Link

Robert Ferris PD-1 targeting in cancer immunotherapy Cancer 119

Version of Record online: 5 OCT 2012 | DOI: 10.1002/cncr.27832

This Web-only perspective commentary discusses a new class of monoclonal antibodies that have garnered tremendous enthusiasm within the field of cancer immunotherapy, which has previously been hampered by complex, cumbersome agents and cells; individualized and laborious preparations; and questionable clinical efficacy.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field